Effects of tanshinoneII A on endothelial progenitor cells from peripheral blood in patients with type 2 diabetes mellitus.
Feng Xiao-fen
Abstract
Feng Xiao-fen
Abstract
Objective To study the effect of tanshinoneⅡA (TanⅡA) on endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus(T2DM).Methods 62 cases patients with T2DM were randomly divided into treatment and control groups. TanⅡA 40mg/d were given for two weeks based on the routine treatment in patients of treatment group. The level of plasma Stromal cell-derived factor-1 (SDF-1),the number of EPCs and the positive rate of CXCR4 were determined before and after treatment.Results Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre and post treatment (P0.05 or P0.01);and those had significant difference between two groups (P0.05 or P0.01). There was a significant positive correlation between EPCs and SDF-1 (r=0.223,P0.05).Conclusion TanshinoneⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization in bone marrow to peripheral blood.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the effect of tanshinoneⅡA (TanⅡA) on endothelial progenitor cells (EPCs) in patients with type 2 diabetes mellitus(T2DM).Methods 62 cases patients with T2DM were randomly divided into treatment and control groups. TanⅡA 40mg/d were given for two weeks based on the routine treatment in patients of treatment group. The level of plasma Stromal cell-derived factor-1 (SDF-1),the number of EPCs and the positive rate of CXCR4 were determined before and after treatment.Results Increasing SDF-1,EPCs and CXCR4 had significant difference in the treatment group pre and post treatment (P0.05 or P0.01);and those had significant difference between two groups (P0.05 or P0.01). There was a significant positive correlation between EPCs and SDF-1 (r=0.223,P0.05).Conclusion TanshinoneⅡA can improve vascular endothelial function in T2DM,which may be due to elevating the level of plasma SDF-1 and increasing the expression of CXCR4 on EPCs,and inducing EPCs mobilization in bone marrow to peripheral blood.
Key concepts: Medicine, Progenitor cell, Stromal cell-derived factor 1, CXCR4, Type 2 Diabetes Mellitus, Stromal cell, Endothelial progenitor cell, Peripheral blood